Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
S&L: Slow and Low Start of Tacrolimus in Renal Transplantation
NCT03672110Phase 3Active, not recruiting
- Sponsor
- Technische Universität Dresden
- Start
- Sep 2014
- Primary completion
- Feb 2020
- Modality
- RNA-Targeting Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of tacrolimus in kidney transplant rejection, sponsored by Technische Universität Dresden. Started Sep 2014; status: active, not recruiting.
02
Drugs
tacrolimus
03
Conditions
kidney transplant rejection
Beyond the preview
Go deeper on NCT03672110.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03672110.